Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients
2019 ◽
Vol Volume 11
◽
pp. 3153-3162
◽
Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours
2009 ◽
Vol 20
(4)
◽
pp. 373-375
Poor survival outcomes in HER2 positive breast cancer patients with low grade, node negative tumours
2008 ◽
Vol 6
(9)
◽
pp. 105-106
Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours
2009 ◽
Vol 100
(5)
◽
pp. 680-683
◽
2010 ◽
Vol 3
(3)
◽
pp. 109-115
◽
2017 ◽
2015 ◽
Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours
2009 ◽
Vol 2009
◽
pp. 185-187